Analysts prepare for the start of trading during the initial public offering of Juno Therapeutics Inc. at the Nasdaq MarketSite in New York, U.S. (Photographer: Victor J. Blue/Bloomberg)

Stocks Radar: Advanced Enzymes, KNR Constructions, Tata Motors, Wipro

Indian stocks tracked declines in their Asian peers after a European Central Bank cut to economic forecasts reignited concerns on global growth. The S&P BSE Sensex and the NSE Nifty 50 Index fell 0.3 percent each to 36,628 and 11,017.75, respectively, as of 10:00 a.m.

The market breadth was tilted in favour of sellers. Ten of the 11 sectoral gauges compiled by the National Stock Exchange declined, led by a 1.36 percent fall in the NSE Nifty Metal Index. The NSE Nifty FMCG Index was the only sectoral gainer, up 0.18 percent.

Here Are The Stocks Moving The Market This Morning:

Wipro Slumps After Block Deal

Shares of the IT firm declined close to 4.8 percent, the most in nearly two months, to Rs 256 apiece.

Around 0.4 percent of equity or as much as 2.67 crore shares were traded in a single block on the BSE, according to Bloomberg data. Buyers and sellers weren't known immediately.

BloombergQuint earlier reported that Azim Premji Trust is said to sell 0.29 percent stake in the company with option to sell up to 0.44 percent through a block deal, citing people aware of the matter. The indicative price range is at Rs 255.40-260.78 per share, implying a discount of 3-5 percent to last close.

Trading volume was more than 70 times its 20-day average for this time of the day, according to Bloomberg data. The stock traded at 16.5 times its estimated forward earnings per share compared with 15.2 times for the two-year historical average.

Stocks Radar: Advanced Enzymes, KNR Constructions, Tata Motors, Wipro

Tata Motors Falls After Jaguar Land Rover Sales Decline

Shares of the carmaker fell 1.7 percent to Rs 186 per share.

JLR’s February retail sales were down 4.1 percent over last year at 38,288 units, according an exchange filing. Jaguar sales were up 5.8 percent and Land Rover sales were down 8.1 percent. Retail sales rose 25.4 percent in North America, grew 11.3 percent in the U.K. and 1.1 percent in Europe. China sales declined 47.6 percent, the filing said.

The stock declined 46 percent in the past 12 months compared with a 11 percent gain in the BSE Sensex.

KNR Constructions At Seven-Month High After Winning Order

Shares of the Hyderabad-based construction company rose for the fifth straight session and gained 6.1 percent intraday to Rs 248.95 apiece, its highest since August last year. The stock has returned as much as 21 percent in the last five trading sessions.

KNR Constructions bagged an order worth Rs 135 crore from Karnataka Road Development Corporation, according to its notification to the exchanges. The firm also bagged a hybrid annuity project with bid project cost of Rs 920 crore.

Trading volume on the stock was more than 50 times the 20-day average for this time of the day, according to data compiled by Bloomberg.

Advanced Enzyme Surges The Most In Nearly Three Years After Block Deals

Shares of Advanced Enzyme Technologies rose as much as 20 percent, the most since August 2016 to Rs 195.45.

About one crore shares of the specialty chemicals company changed hands in two block deals on BSE and NSE, Bloomberg data showed. Buyers and sellers weren't known immediately.

Trading volume was more than 250 times its 20-day average, according to Bloomberg data. The Relative Strength Index was above 70, indicating that the stock may be overbought.

BLS International Gains After Pact With Vietnam Embassy

Shares of the administrative support services provider rose for the second successive day after it gained close to 4.3 percent to Rs 116.40 apiece.

The Embassy of Vietnam signed a deal with the company to accept visa applications in India, according to an exchange filing. The company will accept visa applications for travel to Vietnam at 15 centres, including New Delhi, Mumbai and Chennai, the filing said.

All three analysts tracked by Bloomberg had a ‘Buy’ recommendation on the stock.